Convalescence clinical trials at UC Health
1 research study open to eligible people
open to eligible people ages 18 years and up
Evaluate the efficacy of treatment with high-titer Anti- SARS-CoV-2 plasma versus control (SARS-CoV-2 non-immune plasma) in subjects exposed to Coronavirus disease (COVID-19) at day 28.
at UC Irvine UCLA UCSD